{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:43:44Z","timestamp":1762821824412,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"am","delay-in-days":322,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.retram.2021.103322","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T05:17:26Z","timestamp":1637299046000},"page":"103322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beneficial outcomes and epidemiologics of atypical electrophoretic profiles arising after allogeneic hematopoietic stem cell transplantation for myeloid malignancies"],"prefix":"10.1016","volume":"70","author":[{"given":"Kaies","family":"Hedhli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin","family":"Clichet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amandine","family":"Charbonnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Castelain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Galmiche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Marolleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Caulier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chlo\u00e9","family":"Sauzay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.retram.2021.103322_bib0001","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/bmt.2016.167","article-title":"Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT","volume":"51","author":"Tsirigotis","year":"2016","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.retram.2021.103322_bib0002","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood.V74.8.2764.2764","article-title":"Monoclonal and oligoclonal gammopathy after bone marrow transplantation","volume":"74","author":"Mitus","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.retram.2021.103322_bib0003","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00007890-198703000-00028","article-title":"Frequent occurrence of monoclonal gammopathies with an imbalanced light-chain ratio following bone marrow transplantation","volume":"43","author":"Hammarstr\u00f6m","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.retram.2021.103322_bib0004","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/1042819031000139729","article-title":"Paraproteinemia after hematopoietic stem cell transplantation","volume":"45","author":"Nagashima","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.retram.2021.103322_bib0005","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s10875-010-9454-x","article-title":"Prospective evaluation of epstein\u2013barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy","volume":"30","author":"Chiusolo","year":"2010","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.retram.2021.103322_bib0006","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/00007890-199004000-00015","article-title":"Prospective study of the occurrence of monoclonal gammapathies following bone marrow transplantation in young children","volume":"49","author":"Fischer","year":"1990","journal-title":"Transplantation"},{"key":"10.1016\/j.retram.2021.103322_bib0007","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/sj.bmt.1705805","article-title":"Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation: association with chronic graft-versus-host disease and improved overall survival","volume":"40","author":"Lim","year":"2007","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.retram.2021.103322_bib0008","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1365-2141.1996.7592380.x","article-title":"CMV infection after allogeneic bone marrow transplantations is associated with the occurence of various autoantibodies and monoclonal gammopathies","volume":"95","author":"Hebart","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.retram.2021.103322_bib0009","doi-asserted-by":"crossref","first-page":"106333","DOI":"10.18632\/oncotarget.22462","article-title":"Transient paraproteinemia after allogeneic hematopoietic stem cell transplantation is an underexplored phenomenon associated with graft versus host disease","volume":"8","author":"Widmer","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.retram.2021.103322_bib0010","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1086\/344465","article-title":"High rate of monoclonal gammopathy among immunocompetent subjects with primary cytomegalovirus infection","volume":"35","author":"B\u00fchler","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.retram.2021.103322_bib0011","article-title":"Oligo-monoclonal immunoglobulins frequently develop during concurrent cytomegalovirus (CMV) and Epstein\u00b1Barr virus (EBV) infections in patients after renal transplantation","volume":"8","author":"Drouet","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.retram.2021.103322_bib0012","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00007890-199802150-00018","article-title":"Prevalence of monoclonal immunoglobulines after liver transplantation: relationship with posttransplant lymphoproliferative disorders","volume":"65","author":"Pageaux","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.retram.2021.103322_bib0013","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2141.2010.08224.x","article-title":"The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation: review","volume":"150","author":"Shaw","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.retram.2021.103322_bib0014","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41571-020-0356-4","article-title":"Dissecting the biology of allogeneic HSCT to enhance the GvT effect whilst minimizing GvHD","volume":"17","author":"Blazar","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.retram.2021.103322_bib0015","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nri3212","article-title":"Advances in graft-versus-host disease biology and therapy","volume":"12","author":"Blazar","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.retram.2021.103322_bib0016","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2014-02-514745","article-title":"The biology of graft-versus-host disease: experimental systems instructing clinical practice","volume":"124","author":"Markey","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.retram.2021.103322_bib0017","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0165-2478(00)00270-4","article-title":"Immune reconstitution: an important component of a successful allogeneic transplantation","volume":"74","author":"Paloczi","year":"2000","journal-title":"Immunol Lett"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318621000489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318621000489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:39:55Z","timestamp":1762821595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318621000489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2452318621000489"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2021.103322","relation":{},"ISSN":["2452-3186"],"issn-type":[{"type":"print","value":"2452-3186"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beneficial outcomes and epidemiologics of atypical electrophoretic profiles arising after allogeneic hematopoietic stem cell transplantation for myeloid malignancies","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2021.103322","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103322"}}